組換えコラーゲン基盤生体材料の世界市場レポート2025-2031

QY Research > レポート一覧 > 化学及び材料 > 組換えコラーゲン基盤生体材料の世界市場レポート2025-2031

英文タイトル： Global Recombinant Collagen-Based Biomaterial Market Outlook, In‑Depth Analysis & Forecast to 2031

レポートID：1337140
発表時期：2025-08-05
訪問回数：5
ページ数：136
レポート形式：PDF
レポート言語：英語、日本語
グラフ数：135
レポートカテゴリ：化学及び材料

販売価格（消費税別）

個人版
詳細
マルチユーザー版
詳細
企業版
詳細

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=160.00円。
※米ドル表示価格+10％消費税。

英語版

日本語版

英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=160.00円。
※米ドル表示価格+10％消費税。

お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合，注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。但し、日本語版が必要な場合は、受注後8～10営業日となります。お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

概要

本報告書は、組換えコラーゲン基盤生体材料の世界市場について、容量、生産量、収益、価格の概要を紹介します。2021年から2025年までの過去の市場収益/売上データ、2026年の予測データ、ならびに2032年までのCAGR（年平均成長率）予測を含む、世界市場動向の分析を提供します。本レポートは、メーカー、地域、製品種類、およびエンドユーザー産業の観点から、世界と主要地域の市場現状と将来性を研究したものです。世界と主要地域のトップメーカーを分析し、製品タイプおよびアプリケーション/エンドユーザー産業別に組換えコラーゲン基盤生体材料市場を分類しています。

本レポートでは、世界の組換えコラーゲン基盤生体材料市場の主要参加企業として、企業概要、販売数量、収益、価格、粗利益率、製品ポートフォリオ、地理的位置、主要な事業展開を以下のパラメータに基づいて紹介します。
本レポートは組換えコラーゲン基盤生体材料の主要生産者を調査するとともに、主要地域や国の消費状況も提供します。組換えコラーゲン基盤生体材料の主要地域／国における将来の市場ポテンシャルを重点的に分析し、それに基づき、異なるセグメントおよびサブセグメントにおける市場の将来動向を予測しております。アメリカ、カナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、その他の国々について、各国データおよび市場価値分析を提供しております。
2021年から2032年までの期間について、タイプ別および用途別の売上高、収益、価格に基づくセグメントデータを分析します。

本研究に含まれる主な企業は以下の通りです：
Evonik Industries
Trautec
Genemedicine
FibroGen
CollPlant
Geltor
Modern Meadow

タイプ別市場セグメント：
Medical Grade Recombinant Collagen
Cosmetic Grade Recombinant Collagen
Food Grade Recombinant Collagen
Others

用途別市場セグメント：
Medical Industry
Cosmetic Industry
Food Industry
Others

地域別の市場セグメント：
北米
アジア太平洋
欧州
中南米
中東・アフリカ

本レポートの詳細内容：
世界の組換えコラーゲン基盤生体材料市場の現状と将来展望を包括的に分析し、グローバル主要地域における開発動向の綿密な調査を通じて、企業様に包括的な市場分析を提示します。市場の全体像を把握するため、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて組換えコラーゲン基盤生体材料市場を細分化しています。この分類と用途分析により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2021年から2026年までの実績と2032年までの予測として、メーカー別、地域別（地域レベル、国レベル）の組換えコラーゲン基盤生体材料生産量、成長率、市場シェアを調査しています。
二. 消費面では、組換えコラーゲン基盤生体材料の売上高について、地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2021年から2026年まで、および2032年までの予測を対象とします。
三. 主要メーカーの組換えコラーゲン基盤生体材料売上高、収益、市場シェア、業界ランキングについて、2021年から2026年までのデータに焦点を当てています。世界の組換えコラーゲン基盤生体材料市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づく競争状況と市場ポジショニングの分析を行います。
四. 本組換えコラーゲン基盤生体材料レポートは、関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立案するのに役立つ洞察を提供することを目的としています。売上高、成長動向、生産技術、用途、エンドユーザー産業に関する市場規模の詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。
章節目次：
第1章：組換えコラーゲン基盤生体材料レポートの範囲、市場セグメント（タイプ別、用途別など）ごとの市場規模、将来の発展可能性などをまとめたエグゼクティブサマリーをご紹介いたします。これにより、市場の最新状況を包括的に把握し、短期・中期・長期（2021-2032年）にわたる発展の見通しを把握いただけます。
第2章：組換えコラーゲン基盤生体材料の世界および主要生産者（地域／国別）の生産量／アウトプットについて分析します。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています（2021年～2032年）
第3章：組換えコラーゲン基盤生体材料の現在の市場状況を提示し、2032年までの世界的な収益・販売・生産を予測するとともに、消費量の多い地域と新興市場の成長要因を特定します（2021年～2032年）
第4章：組換えコラーゲン基盤生体材料メーカーの競争状況、価格、売上高、収益、市場シェア、業界ランキング、最新の開発計画、合併・買収情報など詳細に分析します（2021年～2026年）
第5章：組換えコラーゲン基盤生体材料の下流市場機会を特定し、用途別販売量・収益・価格設定を評価するとともに新興ユースケースを明らかにし、地域別・用途別の主要顧客をプロファイリングします
第6章：組換えコラーゲン基盤生体材料のグローバル生産能力、稼働率、市場シェア（2021-2032年）をマッピングし、効率的拠点を特定するとともに規制や貿易政策の影響とボトルネックを解明します
第7章：北米における組換えコラーゲン基盤生体材料市場をアプリケーション別・国別売上高・収益で分析し、主要メーカーをプロファイリングしつつ成長要因と障壁を評価します
第8章：欧州における組換えコラーゲン基盤生体材料市場をアプリケーション別・メーカー別に地域別売上高・収益・市場分析を行い、成長要因と障壁を明示します
第9章：アジア太平洋地域の組換えコラーゲン基盤生体材料市場を用途別・地域/国別の売上高と収益で定量化し、主要メーカーをプロファイリングするとともに高成長潜在地域を明らかにします
第10章：中南米における組換えコラーゲン基盤生体材料市場を用途別・国別売上高と収益で測定し、主要メーカーをプロファイリングするとともに投資機会と課題を特定します
第11章：中東・アフリカ地域の組換えコラーゲン基盤生体材料市場を用途別・国別に評価し、主要メーカーをプロファイリングするとともに投資見通しと市場障壁を概説します
第12章：組換えコラーゲン基盤生体材料の主要メーカーの概要を提供し、製品説明、売上高、収益、価格、粗利益率、最近の事業拡大などの情報を整理するとともに、SWOT分析および戦略動向分析を行います
第13章：組換えコラーゲン基盤生体材料のサプライチェーンを分析し、上流の原材料・供給業者、製造拠点と技術、コスト要因を明らかにします
第14章：組換えコラーゲン基盤生体材料の市場動向、最新動向、推進要因と制約要因、業界内のメーカーが直面する課題とリスク、関連する業界政策の分析を紹介します
第15章：レポートの要点と結論
第16章：付録

Description

The global Recombinant Collagen-Based Biomaterial market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.

Recombinant collagen-based biomaterials are produced through biotechnology, with advantages such as high purity, good quality consistency, and no animal pathogens, which greatly reduces the risk of immune response. This material shows broad application prospects in the fields of medicine, pharmaceuticals, cosmetics, food, and bioprinting. In medicine, recombinant collagen is used in tissue engineering and wound repair to promote tissue regeneration and healing; in the cosmetic field, it has become an important ingredient in skin care products due to its excellent moisturizing and anti-aging properties; in food and nutritional supplements, recombinant collagen provides health and beauty benefits and supports joint and skin health. In addition, recombinant collagen is used in 3D bioprinting technology to help build complex biological structures and develop tissue engineering. The versatility and safety of this material make it a key factor in promoting innovation and development in multiple industries.

Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Recombinant Collagen-Based Biomaterial market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation
By Company
Evonik Industries
Trautec
Genemedicine
FibroGen
CollPlant
Geltor
Modern Meadow

Segment by Type
Medical Grade Recombinant Collagen
Cosmetic Grade Recombinant Collagen
Food Grade Recombinant Collagen
Others

Segment by Application
Medical Industry
Cosmetic Industry
Food Industry
Others

Production by Region
North America
Europe
China
Japan

Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina

Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa

Chapter Outline
Chapter 1: Defines the Recombinant Collagen-Based Biomaterial study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

Table of Contents

1 Study Coverage
1.1 Introduction to Recombinant Collagen-Based Biomaterial: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Recombinant Collagen-Based Biomaterial Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Medical Grade Recombinant Collagen
1.2.3 Cosmetic Grade Recombinant Collagen
1.2.4 Food Grade Recombinant Collagen
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Recombinant Collagen-Based Biomaterial Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Medical Industry
1.3.3 Cosmetic Industry
1.3.4 Food Industry
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Executive Summary
2.1 Global Recombinant Collagen-Based Biomaterial Revenue Estimates and Forecasts 2020-2031
2.2 Global Recombinant Collagen-Based Biomaterial Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Recombinant Collagen-Based Biomaterial Sales Estimates and Forecasts 2020-2031
2.4 Global Recombinant Collagen-Based Biomaterial Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis
3.1 Global Recombinant Collagen-Based Biomaterial Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan

4 Competition by Manufacturers
4.1 Global Recombinant Collagen-Based Biomaterial Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Recombinant Collagen-Based Biomaterial Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Medical Grade Recombinant Collagen Market Size by Manufacturers
4.5.2 Cosmetic Grade Recombinant Collagen Market Size by Manufacturers
4.5.3 Food Grade Recombinant Collagen Market Size by Manufacturers
4.5.4 Others Market Size by Manufacturers
4.6 Global Recombinant Collagen-Based Biomaterial Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis
5.1 Global Recombinant Collagen-Based Biomaterial Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Recombinant Collagen-Based Biomaterial Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats

6 Global Downstream Application Analysis
6.1 Global Recombinant Collagen-Based Biomaterial Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Recombinant Collagen-Based Biomaterial Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application

7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Recombinant Collagen-Based Biomaterial Sales and Revenue by Type (2020-2031)
7.4 North America Recombinant Collagen-Based Biomaterial Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Recombinant Collagen-Based Biomaterial Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico

8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Recombinant Collagen-Based Biomaterial Sales and Revenue by Type (2020-2031)
8.4 Europe Recombinant Collagen-Based Biomaterial Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Recombinant Collagen-Based Biomaterial Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia

9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Recombinant Collagen-Based Biomaterial Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Recombinant Collagen-Based Biomaterial Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Recombinant Collagen-Based Biomaterial Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India

10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Recombinant Collagen-Based Biomaterial Sales and Revenue by Type (2020-2031)
10.4 Central and South America Recombinant Collagen-Based Biomaterial Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Recombinant Collagen-Based Biomaterial Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Recombinant Collagen-Based Biomaterial Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Recombinant Collagen-Based Biomaterial Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Recombinant Collagen-Based Biomaterial Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa

12 Corporate Profile
12.1 Evonik Industries
12.1.1 Evonik Industries Corporation Information
12.1.2 Evonik Industries Business Overview
12.1.3 Evonik Industries Recombinant Collagen-Based Biomaterial Product Models, Descriptions and Specifications
12.1.4 Evonik Industries Recombinant Collagen-Based Biomaterial Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Evonik Industries Recombinant Collagen-Based Biomaterial Sales by Product in 2024
12.1.6 Evonik Industries Recombinant Collagen-Based Biomaterial Sales by Application in 2024
12.1.7 Evonik Industries Recombinant Collagen-Based Biomaterial Sales by Geographic Area in 2024
12.1.8 Evonik Industries Recombinant Collagen-Based Biomaterial SWOT Analysis
12.1.9 Evonik Industries Recent Developments
12.2 Trautec
12.2.1 Trautec Corporation Information
12.2.2 Trautec Business Overview
12.2.3 Trautec Recombinant Collagen-Based Biomaterial Product Models, Descriptions and Specifications
12.2.4 Trautec Recombinant Collagen-Based Biomaterial Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Trautec Recombinant Collagen-Based Biomaterial Sales by Product in 2024
12.2.6 Trautec Recombinant Collagen-Based Biomaterial Sales by Application in 2024
12.2.7 Trautec Recombinant Collagen-Based Biomaterial Sales by Geographic Area in 2024
12.2.8 Trautec Recombinant Collagen-Based Biomaterial SWOT Analysis
12.2.9 Trautec Recent Developments
12.3 Genemedicine
12.3.1 Genemedicine Corporation Information
12.3.2 Genemedicine Business Overview
12.3.3 Genemedicine Recombinant Collagen-Based Biomaterial Product Models, Descriptions and Specifications
12.3.4 Genemedicine Recombinant Collagen-Based Biomaterial Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Genemedicine Recombinant Collagen-Based Biomaterial Sales by Product in 2024
12.3.6 Genemedicine Recombinant Collagen-Based Biomaterial Sales by Application in 2024
12.3.7 Genemedicine Recombinant Collagen-Based Biomaterial Sales by Geographic Area in 2024
12.3.8 Genemedicine Recombinant Collagen-Based Biomaterial SWOT Analysis
12.3.9 Genemedicine Recent Developments
12.4 FibroGen
12.4.1 FibroGen Corporation Information
12.4.2 FibroGen Business Overview
12.4.3 FibroGen Recombinant Collagen-Based Biomaterial Product Models, Descriptions and Specifications
12.4.4 FibroGen Recombinant Collagen-Based Biomaterial Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 FibroGen Recombinant Collagen-Based Biomaterial Sales by Product in 2024
12.4.6 FibroGen Recombinant Collagen-Based Biomaterial Sales by Application in 2024
12.4.7 FibroGen Recombinant Collagen-Based Biomaterial Sales by Geographic Area in 2024
12.4.8 FibroGen Recombinant Collagen-Based Biomaterial SWOT Analysis
12.4.9 FibroGen Recent Developments
12.5 CollPlant
12.5.1 CollPlant Corporation Information
12.5.2 CollPlant Business Overview
12.5.3 CollPlant Recombinant Collagen-Based Biomaterial Product Models, Descriptions and Specifications
12.5.4 CollPlant Recombinant Collagen-Based Biomaterial Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 CollPlant Recombinant Collagen-Based Biomaterial Sales by Product in 2024
12.5.6 CollPlant Recombinant Collagen-Based Biomaterial Sales by Application in 2024
12.5.7 CollPlant Recombinant Collagen-Based Biomaterial Sales by Geographic Area in 2024
12.5.8 CollPlant Recombinant Collagen-Based Biomaterial SWOT Analysis
12.5.9 CollPlant Recent Developments
12.6 Geltor
12.6.1 Geltor Corporation Information
12.6.2 Geltor Business Overview
12.6.3 Geltor Recombinant Collagen-Based Biomaterial Product Models, Descriptions and Specifications
12.6.4 Geltor Recombinant Collagen-Based Biomaterial Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Geltor Recent Developments
12.7 Modern Meadow
12.7.1 Modern Meadow Corporation Information
12.7.2 Modern Meadow Business Overview
12.7.3 Modern Meadow Recombinant Collagen-Based Biomaterial Product Models, Descriptions and Specifications
12.7.4 Modern Meadow Recombinant Collagen-Based Biomaterial Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Modern Meadow Recent Developments

13 Value Chain and Supply-Chain Analysis
13.1 Recombinant Collagen-Based Biomaterial Industry Chain
13.2 Recombinant Collagen-Based Biomaterial Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Recombinant Collagen-Based Biomaterial Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Recombinant Collagen-Based Biomaterial Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors

14 Recombinant Collagen-Based Biomaterial Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global Recombinant Collagen-Based Biomaterial Study

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details

Table of Figures

List of Tables
 Table 1. Global Recombinant Collagen-Based Biomaterial Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Recombinant Collagen-Based Biomaterial Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Recombinant Collagen-Based Biomaterial Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Recombinant Collagen-Based Biomaterial Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Recombinant Collagen-Based Biomaterial Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Recombinant Collagen-Based Biomaterial Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Recombinant Collagen-Based Biomaterial Sales by Region (2020-2025) & (Tons)
 Table 8. Global Recombinant Collagen-Based Biomaterial Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Recombinant Collagen-Based Biomaterial Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global Recombinant Collagen-Based Biomaterial Production by Region (2020-2025) & (Tons)
 Table 12. Global Recombinant Collagen-Based Biomaterial Production by Region (2026-2031) & (Tons)
 Table 13. Global Recombinant Collagen-Based Biomaterial Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global Recombinant Collagen-Based Biomaterial Sales Share by Manufacturers (2020-2025)
 Table 15. Global Recombinant Collagen-Based Biomaterial Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Recombinant Collagen-Based Biomaterial Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Recombinant Collagen-Based Biomaterial by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Collagen-Based Biomaterial as of 2024)
 Table 19. Global Recombinant Collagen-Based Biomaterial Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Recombinant Collagen-Based Biomaterial Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers Recombinant Collagen-Based Biomaterial Manufacturing Base and Headquarters
 Table 22. Global Recombinant Collagen-Based Biomaterial Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Recombinant Collagen-Based Biomaterial Sales by Type (2020-2025) & (Tons)
 Table 26. Global Recombinant Collagen-Based Biomaterial Sales by Type (2026-2031) & (Tons)
 Table 27. Global Recombinant Collagen-Based Biomaterial Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Recombinant Collagen-Based Biomaterial Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Recombinant Collagen-Based Biomaterial ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Recombinant Collagen-Based Biomaterial Sales by Application (2020-2025) & (Tons)
 Table 32. Global Recombinant Collagen-Based Biomaterial Sales by Application (2026-2031) & (Tons)
 Table 33. Recombinant Collagen-Based Biomaterial High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Recombinant Collagen-Based Biomaterial Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Recombinant Collagen-Based Biomaterial Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Recombinant Collagen-Based Biomaterial ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Recombinant Collagen-Based Biomaterial Growth Accelerators and Market Barriers
 Table 40. North America Recombinant Collagen-Based Biomaterial Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Recombinant Collagen-Based Biomaterial Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Recombinant Collagen-Based Biomaterial Growth Accelerators and Market Barriers
 Table 43. Europe Recombinant Collagen-Based Biomaterial Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Recombinant Collagen-Based Biomaterial Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Recombinant Collagen-Based Biomaterial Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Recombinant Collagen-Based Biomaterial Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Recombinant Collagen-Based Biomaterial Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Recombinant Collagen-Based Biomaterial Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Recombinant Collagen-Based Biomaterial Investment Opportunities and Key Challenges
 Table 50. Central and South America Recombinant Collagen-Based Biomaterial Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Recombinant Collagen-Based Biomaterial Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Recombinant Collagen-Based Biomaterial Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Evonik Industries Corporation Information
 Table 54. Evonik Industries Description and Major Businesses
 Table 55. Evonik Industries Product Models, Descriptions and Specifications
 Table 56. Evonik Industries Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. Evonik Industries Sales Value Proportion by Product in 2024
 Table 58. Evonik Industries Sales Value Proportion by Application in 2024
 Table 59. Evonik Industries Sales Value Proportion by Geographic Area in 2024
 Table 60. Evonik Industries Recombinant Collagen-Based Biomaterial SWOT Analysis
 Table 61. Evonik Industries Recent Developments
 Table 62. Trautec Corporation Information
 Table 63. Trautec Description and Major Businesses
 Table 64. Trautec Product Models, Descriptions and Specifications
 Table 65. Trautec Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. Trautec Sales Value Proportion by Product in 2024
 Table 67. Trautec Sales Value Proportion by Application in 2024
 Table 68. Trautec Sales Value Proportion by Geographic Area in 2024
 Table 69. Trautec Recombinant Collagen-Based Biomaterial SWOT Analysis
 Table 70. Trautec Recent Developments
 Table 71. Genemedicine Corporation Information
 Table 72. Genemedicine Description and Major Businesses
 Table 73. Genemedicine Product Models, Descriptions and Specifications
 Table 74. Genemedicine Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Genemedicine Sales Value Proportion by Product in 2024
 Table 76. Genemedicine Sales Value Proportion by Application in 2024
 Table 77. Genemedicine Sales Value Proportion by Geographic Area in 2024
 Table 78. Genemedicine Recombinant Collagen-Based Biomaterial SWOT Analysis
 Table 79. Genemedicine Recent Developments
 Table 80. FibroGen Corporation Information
 Table 81. FibroGen Description and Major Businesses
 Table 82. FibroGen Product Models, Descriptions and Specifications
 Table 83. FibroGen Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. FibroGen Sales Value Proportion by Product in 2024
 Table 85. FibroGen Sales Value Proportion by Application in 2024
 Table 86. FibroGen Sales Value Proportion by Geographic Area in 2024
 Table 87. FibroGen Recombinant Collagen-Based Biomaterial SWOT Analysis
 Table 88. FibroGen Recent Developments
 Table 89. CollPlant Corporation Information
 Table 90. CollPlant Description and Major Businesses
 Table 91. CollPlant Product Models, Descriptions and Specifications
 Table 92. CollPlant Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. CollPlant Sales Value Proportion by Product in 2024
 Table 94. CollPlant Sales Value Proportion by Application in 2024
 Table 95. CollPlant Sales Value Proportion by Geographic Area in 2024
 Table 96. CollPlant Recombinant Collagen-Based Biomaterial SWOT Analysis
 Table 97. CollPlant Recent Developments
 Table 98. Geltor Corporation Information
 Table 99. Geltor Description and Major Businesses
 Table 100. Geltor Product Models, Descriptions and Specifications
 Table 101. Geltor Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 102. Geltor Recent Developments
 Table 103. Modern Meadow Corporation Information
 Table 104. Modern Meadow Description and Major Businesses
 Table 105. Modern Meadow Product Models, Descriptions and Specifications
 Table 106. Modern Meadow Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 107. Modern Meadow Recent Developments
 Table 108. Key Raw Materials Distribution
 Table 109. Raw Materials Key Suppliers
 Table 110. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 111. Milestones in Production Technology Evolution
 Table 112. Distributors List
 Table 113. Market Trends and Market Evolution
 Table 114. Market Drivers and Opportunities
 Table 115. Market Challenges, Risks, and Restraints
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources


List of Figures
 Figure 1. Recombinant Collagen-Based Biomaterial Product Picture
 Figure 2. Global Recombinant Collagen-Based Biomaterial Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Medical Grade Recombinant Collagen Product Picture
 Figure 4. Cosmetic Grade Recombinant Collagen Product Picture
 Figure 5. Food Grade Recombinant Collagen Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Recombinant Collagen-Based Biomaterial Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Medical Industry
 Figure 9. Cosmetic Industry
 Figure 10. Food Industry
 Figure 11. Others
 Figure 12. Recombinant Collagen-Based Biomaterial Report Years Considered
 Figure 13. Global Recombinant Collagen-Based Biomaterial Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Recombinant Collagen-Based Biomaterial Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Recombinant Collagen-Based Biomaterial Revenue Market Share by Region (2020-2031)
 Figure 17. Global Recombinant Collagen-Based Biomaterial Sales (2020-2031) & (Tons)
 Figure 18. Global Recombinant Collagen-Based Biomaterial Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 19. Global Recombinant Collagen-Based Biomaterial Sales Market Share by Region (2020-2031)
 Figure 20. Global Recombinant Collagen-Based Biomaterial Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 21. Global Recombinant Collagen-Based Biomaterial Production Trend by Region (2020-2031) (Tons)
 Figure 22. Global Recombinant Collagen-Based Biomaterial Production Market Share by Region (2020-2031)
 Figure 23. Production Capacity Enablers & Constraints
 Figure 24. Recombinant Collagen-Based Biomaterial Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 25. Recombinant Collagen-Based Biomaterial Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 26. Recombinant Collagen-Based Biomaterial Production Growth Rate in China (2020-2031) & (Tons)
 Figure 27. Recombinant Collagen-Based Biomaterial Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 28. Top 5 and Top 10 Manufacturers Recombinant Collagen-Based Biomaterial Sales Volume Market Share in 2024
 Figure 29. Global Recombinant Collagen-Based Biomaterial Revenue Market Share Ranking (2024)
 Figure 30. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 31. Medical Grade Recombinant Collagen Revenue Market Share by Manufacturer in 2024
 Figure 32. Cosmetic Grade Recombinant Collagen Revenue Market Share by Manufacturer in 2024
 Figure 33. Food Grade Recombinant Collagen Revenue Market Share by Manufacturer in 2024
 Figure 34. Others Revenue Market Share by Manufacturer in 2024
 Figure 35. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 36. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 37. Global Recombinant Collagen-Based Biomaterial Sales Market Share by Type (2020-2031)
 Figure 38. Global Recombinant Collagen-Based Biomaterial Revenue Market Share by Type (2020-2031)
 Figure 39. Global Recombinant Collagen-Based Biomaterial Sales Market Share by Application (2020-2031)
 Figure 40. Global Recombinant Collagen-Based Biomaterial Revenue Market Share by Application (2020-2031)
 Figure 41. North America Recombinant Collagen-Based Biomaterial Sales YoY (2020-2031) & (Tons)
 Figure 42. North America Recombinant Collagen-Based Biomaterial Revenue YoY (2020-2031) & (US$ Million)
 Figure 43. North America Top 5 Manufacturers Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) in 2024
 Figure 44. North America Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Type (2020- 2031)
 Figure 45. North America Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 46. North America Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Application (2020-2031)
 Figure 47. North America Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 48. US Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 49. Canada Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 50. Mexico Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 51. Europe Recombinant Collagen-Based Biomaterial Sales YoY (2020-2031) & (Tons)
 Figure 52. Europe Recombinant Collagen-Based Biomaterial Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Europe Top 5 Manufacturers Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) in 2024
 Figure 54. Europe Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Type (2020-2031)
 Figure 55. Europe Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 56. Europe Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Application (2020-2031)
 Figure 57. Europe Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 58. Germany Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 59. France Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 60. U.K. Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 61. Italy Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 62. Russia Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 63. Asia-Pacific Recombinant Collagen-Based Biomaterial Sales YoY (2020-2031) & (Tons)
 Figure 64. Asia-Pacific Recombinant Collagen-Based Biomaterial Revenue YoY (2020-2031) & (US$ Million)
 Figure 65. Asia-Pacific Top 8 Manufacturers Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) in 2024
 Figure 66. Asia-Pacific Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Type (2020- 2031)
 Figure 67. Asia-Pacific Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 68. Asia-Pacific Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Application (2020-2031)
 Figure 69. Asia-Pacific Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 70. Indonesia Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 71. Japan Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 72. South Korea Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 73. China Taiwan Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 74. India Recombinant Collagen-Based Biomaterial Revenue (2020-2031) & (US$ Million)
 Figure 75. Central and South America Recombinant Collagen-Based Biomaterial Sales YoY (2020-2031) & (Tons)
 Figure 76. Central and South America Recombinant Collagen-Based Biomaterial Revenue YoY (2020-2031) & (US$ Million)
 Figure 77. Central and South America Top 5 Manufacturers Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) in 2024
 Figure 78. Central and South America Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Type (2021-2031)
 Figure 79. Central and South America Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 80. Central and South America Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Application (2020-2031)
 Figure 81. Central and South America Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 82. Brazil Recombinant Collagen-Based Biomaterial Revenue (2020-2025) & (US$ Million)
 Figure 83. Argentina Recombinant Collagen-Based Biomaterial Revenue (2020-2025) & (US$ Million)
 Figure 84. Middle East, and Africa Recombinant Collagen-Based Biomaterial Sales YoY (2020-2031) & (Tons)
 Figure 85. Middle East and Africa Recombinant Collagen-Based Biomaterial Revenue YoY (2020-2031) & (US$ Million)
 Figure 86. Middle East and Africa Top 5 Manufacturers Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) in 2024
 Figure 87. Middle East and Africa Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Type (2021-2031)
 Figure 88. South America Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 89. Middle East and Africa Recombinant Collagen-Based Biomaterial Sales Volume (Tons) by Application (2020-2031)
 Figure 90. Middle East and Africa Recombinant Collagen-Based Biomaterial Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 91. GCC Countries Recombinant Collagen-Based Biomaterial Revenue (2020-2025) & (US$ Million)
 Figure 92. Turkey Recombinant Collagen-Based Biomaterial Revenue (2020-2025) & (US$ Million)
 Figure 93. Egypt Recombinant Collagen-Based Biomaterial Revenue (2020-2025) & (US$ Million)
 Figure 94. South Africa Recombinant Collagen-Based Biomaterial Revenue (2020-2025) & (US$ Million)
 Figure 95. Recombinant Collagen-Based Biomaterial Industry Chain Mapping
 Figure 96. Regional Recombinant Collagen-Based Biomaterial Manufacturing Base Distribution (%)
 Figure 97. Recombinant Collagen-Based Biomaterial Production Process
 Figure 98. Regional Recombinant Collagen-Based Biomaterial Production Cost Structure
 Figure 99. Channels of Distribution (Direct Vs Distribution)
 Figure 100. Bottom-up and Top-down Approaches for This Report
 Figure 101. Data Triangulation
 Figure 102. Key Executives Interviewed

以下、関連資料のご紹介